RTTNews | Dec 22, 2021 10:33AM EST

10:33 Wednesday, December 22, 2021 (RTTNews.com) - BioRestorative Therapies, Inc. (BRTX) shares are gaining more than 18 percent on Wednesday morning trade after the company announced a Master Service Agreement with the contract research organization - PRC Clinical for Phase 2 clinical trial.

As per the agreement, PRC Clinical will manage BioRestorative's Phase 2 clinical study of BRTX-100 to treat chronic lumbar disc disease.

Currently, BRTX is trading at $5.39, up 17.94 percent from the previous close of $4.57 on a volume of 7,207,158. The shares have traded in a range of $4.36-$132.00 on average volume of 194,818.

Read the original article on RTTNews ( https://www.rttnews.com/3251160/biorestorative-therapies-rising-on-clinical-trial-agreement-with-prc-clinical.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved